AUPH insider transaction filings
Aurinia Pharmaceuticals Inc. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-08. Screen AUPH transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Goetz Kathleen — Director | Grant/award (A): 23,931 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Bailey Jeffrey Allen — Director | Grant/award (A): 23,931 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Johnson Craig A — Director | Grant/award (A): 23,931 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Nova Tina Susan — Director | Grant/award (A): 23,931 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | TANG KEVIN — Chief Executive Officer, Director, 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner | Purchase (P): 2,299 @ $15.35 · Purchase (P): 262,682 @ $15.31 · Purchase (P): 343,521 @ $15.28 · Purchase (P): 99 @ $15.34 · Purchase (P): 206,005 @ $15.28 · Other (J): 10,000 (derivative) @ $1.65 | EDGAR |
| 2026-05-20 | 4 | Cole Ryan — Chief Operating Officer | Grant/award (A): 116,144 @ $0 · Grant/award (A): 70,230 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Robertson Stephen P. — Chief Legal Officer | Grant/award (A): 115,541 @ $0 | EDGAR |
| 2026-05-20 | 4 | Hearne Michael S — Chief Financial Officer | Grant/award (A): 116,144 @ $0 · Grant/award (A): 70,230 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Keenan Greg — SVP, Chief Medical Officer | Tax withholding (F): 8,069 @ $14.32 | EDGAR |
| 2026-03-03 | 4 | Miller Joseph M — Chief Financial Officer | Grant/award (A): 57,229 @ $0 · Tax withholding (F): 37,511 @ $14.21 · Grant/award (A): 95,700 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Donley Matthew Maxwell — Chief Operating Officer | Grant/award (A): 58,160 @ $0 · Tax withholding (F): 40,761 @ $14.21 · Grant/award (A): 97,256 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Keenan Greg — SVP, Chief Medical Officer | Grant/award (A): 40,586 @ $0 · Grant/award (A): 67,870 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Robertson Stephen P. — EVP, General Counsel | Grant/award (A): 59,090 @ $0 · Tax withholding (F): 36,525 @ $14.21 · Grant/award (A): 98,813 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Greenleaf Peter — Chief Executive Officer, Director | Grant/award (A): 196,403 @ $0 · Tax withholding (F): 100,890 @ $14.21 · Grant/award (A): 328,424 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | TANG KEVIN — Director | Purchase (P): 300,000 @ $13.90 · Purchase (P): 214,839 @ $14.12 · Purchase (P): 1,600 @ $14.38 · Purchase (P): 83,561 @ $14.33 · Purchase (P): 115,792 @ $14.21 · Purchase (P): 184,208 @ $14.22 | EDGAR |
| 2026-02-23 | 4 | Robertson Stephen P. — EVP, General Counsel | Tax withholding (F): 34,638 @ $14.40 | EDGAR |
| 2026-02-23 | 4 | Miller Joseph M — Chief Financial Officer | Tax withholding (F): 32,424 @ $14.40 | EDGAR |
| 2026-02-23 | 4 | Donley Matthew Maxwell — Chief Operating Officer | Tax withholding (F): 32,901 @ $14.40 | EDGAR |
| 2026-02-23 | 4 | Greenleaf Peter — Chief Executive Officer, Director | Tax withholding (F): 100,171 @ $14.40 | EDGAR |
| 2026-02-03 | 4 | Keenan Greg — SVP, Chief Medical Officer | Tax withholding (F): 11,552 @ $14.53 | EDGAR |
| 2026-01-05 | 4 | Robertson Stephen P. — EVP, General Counsel | Grant/award (A): 48,558 @ $0 · Tax withholding (F): 40,385 @ $15.95 | EDGAR |
| 2026-01-05 | 4 | Donley Matthew Maxwell — Chief Operating Officer | Grant/award (A): 54,166 @ $0 · Tax withholding (F): 42,787 @ $15.95 | EDGAR |
| 2026-01-05 | 4 | Miller Joseph M — Chief Financial Officer | Grant/award (A): 49,038 @ $0 · Tax withholding (F): 40,161 @ $15.95 | EDGAR |
| 2026-01-05 | 4 | Greenleaf Peter — Chief Executive Officer, Director | Grant/award (A): 165,384 @ $0 · Tax withholding (F): 113,169 @ $15.95 | EDGAR |
| 2025-11-24 | 4 | Bailey Jeffrey Allen — Director | Tax withholding (F): 2,716 @ $15.68 | EDGAR |
| 2025-11-24 | 4 | Johnson Craig A — Director | Tax withholding (F): 6,039 @ $15.68 | EDGAR |
| 2025-08-05 | 4 | Keenan Greg — Chief Medical Officer | Sale (S): 20,000 @ $10.50 | EDGAR |
| 2025-08-05 | 4 | TANG KEVIN — Director | Purchase (P): 1,000,000 @ $10.12 · Purchase (P): 100,000 @ $11.34 · Purchase (P): 200,000 @ $11.68 | EDGAR |
| 2025-05-16 | 4 | Goetz Kathleen — Director | Grant/award (A): 63,724 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Bailey Jeffrey Allen — Director | Grant/award (A): 37,485 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Johnson Craig A — Director | Grant/award (A): 37,485 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Nova Tina Susan — Director | Grant/award (A): 63,724 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Keenan Greg — Chief Medical Officer | Sale (S): 8,305 @ $8.23 | EDGAR |
| 2025-03-04 | 4 | Keenan Greg — Chief Medical Officer | Grant/award (A): 62,583 @ $0 · Sale (S): 12,239 @ $8 · Grant/award (A): 95,570 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Miller Joseph M — Chief Financial Officer | Grant/award (A): 81,457 @ $0 · Grant/award (A): 114,711 @ $0 · Sale (S): 61,859 @ $8 · Sale (S): 56,154 @ $7.92 · Grant/award (A): 124,393 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Robertson Stephen P. — EVP, General Counsel | Grant/award (A): 84,106 @ $0 · Grant/award (A): 102,406 @ $0 · Sale (S): 64,872 @ $8 · Sale (S): 57,607 @ $7.92 · Grant/award (A): 128,438 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Donley Matthew Maxwell — Chief Operating Officer | Grant/award (A): 82,781 @ $0 · Grant/award (A): 135,567 @ $0 · Sale (S): 65,902 @ $8 · Sale (S): 58,991 @ $7.92 · Grant/award (A): 126,416 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Greenleaf Peter — Chief Executive Officer, Director | Grant/award (A): 290,728 @ $0 · Grant/award (A): 333,705 @ $0 · Sale (S): 195,593 @ $8 · Sale (S): 164,947 @ $7.92 · Grant/award (A): 443,973 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | TANG KEVIN — Director | Purchase (P): 399,280 @ $7.85 · Purchase (P): 100,720 @ $7.97 · Purchase (P): 351,962 @ $8.02 · Purchase (P): 148,038 @ $8 · Purchase (P): 500,000 @ $7.92 · Purchase (P): 100,000 @ $8.09 | EDGAR |
Recent 8-K events — Aurinia Pharmaceuticals Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-19 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-07-31 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AUPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →